Pifeltro (Doravirine)

Save 30% with Pifeltro from Europe.

Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine

Marketing Authorisation Holder and Manufacturer for Europe:
Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, The Netherlands

 

Prescription Pifeltro contains the active ingredient doravirine, used as a treatment for HIV. Pifeltro is classified as a NNRTI (non-nucleoside reverse transcriptase inhibitor) which blocks the activity of the enzyme that allows the HIV virus to reproduce itself.

Although Pifeltro is not a cure for HIV, it helps to keep HIV virus levels at low levels in the blood. Pifeltro is used by adults in combination with other HIV medicines to prevents further damage to the immune system and the development of diseases and infections associated with AIDS. 

Pifeltro, when used together with Truvada (emtricitabine/tenofovir) or Epzicom (abacavir/lamivudine), has shown to produce undetectable levels of the virus after 48 weeks of treatment in 83% of patients. When Pifeltro is used in combination with both Viread (tenofovir) and Epivir (lamivudine), 84% of patients after 48 weeks of treatment have undetectable levels of the HIV virus.

Pifeltro is usually taken once daily with or without food but must be taken every day even if you feel better. Take Pifeltro exactly as prescribed by your physician